VBIO today
$0.52-$0.02 (-4.35%)close Nov 16, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minLeaning Bearish
5 minExpanding
Daily trend turns up above $1.26
Key levels
Resistance$1.04
Resistance$0.57
Latest news & SEC filings
NewsLisa Wolf to leave her three executive roles at Valion Bio on December 11
All VBIO news →About Tivic Health
Tivic Health Systems develops Entolimod, an engineered TLR5 agonist protein, as a countermeasure for acute radiation syndrome and as supportive treatment for cancer therapy side effects including low neutrophil and platelet counts and mucosal damage. It also holds rights to a follow-on compound called Entolasta. A subsidiary, Velocity Bioworks, runs contract development and manufacturing work and a production site in San Antonio, Texas. Customers include government agencies and outside manufacturing clients.
Based on the company's 10-K filed Mar 30, 2026.
Nasdaq · Healthcare
Valion Bio, Inc. (VBIO)
What Is the Price Target for VBIO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is VBIO a Buy or Sell Right Now?
Thesis
- •Revenue growing -33.7% YoY with DECLINING trend — consistent growth.
Test your own strategy on VBIO
Describe your strategy in plain words, then scan, alert, backtest and paper trade it on VBIO with SEPT’s own market data.
Start Free Trial →Is VBIO Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
10
Moat Score
NONE
3/9
Piotroski Score
-2.6
Altman Z-Score
What Is Smart Money Doing with VBIO?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Wolf Lisa G | officer | Buy | 4 | - | Sep 18, 2026 |
| Wolf Lisa G | officer | Sale | 2 | $4.24 | Sep 18, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See Smart Money Data →VBIO Growth Story
Revenue YoY
-33.7%
3yr Revenue CAGR
-14.7%
EPS Growth YoY
N/A
FCF Growth YoY
-22.9%
Revenue Trend
DECLINING
Dark Pool Trades for VBIO
PREVIEWRecent off-exchange (dark pool) prints for VBIO: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:57:34 | $0.56 | 2,477 | $$1K | BUY |
| 24:55:57 | $0.56 | 1,414 | $$787 | BUY |
| 24:39:37 | $0.55 | 2,000 | $$1K | SELL |
| 24:24:51 | $0.55 | 1,404 | $$769 | BUY |
| 23:23:50 | $0.53 | 1,000 | $$534 | BUY |
5 dark pool trades shown · $$5K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Valion Bio, Inc. (VBIO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
Your strategy, tested before real money.
Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.
Try SEPT Free for 7 Days →VBIO — frequently asked questions
What is VBIO stock price today?
Valion Bio, Inc. (VBIO) is at $0.52, down 4.35% (-$0.02) at the Nov 16, 2026 close.
Why is VBIO stock moving today?
Latest VBIO news — Nov 5, 2026: Lisa Wolf to leave her three executive roles at Valion Bio on December 11
Did VBIO beat earnings?
VBIO last reported on Aug 14, 2026: EPS -$54.25 vs -$10200.00 expected — a beat of 99.5%.
What are VBIO support and resistance levels?
Resistance: $0.57, $1.04, $1.26.
What are insiders doing with VBIO?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on VBIO?
Nov 5, 2026: Lisa Wolf to leave her three executive roles at Valion Bio on December 11